04.06.2025 07:00 | AREC | Grant of Options and PDMR Dealing | RNS |
02.06.2025 13:32 | AREC | Result of AGM | RNS |
02.06.2025 07:00 | AREC | Non-Executive Director Board Change | RNS |
21.05.2025 07:00 | AREC | Director/PDMR Dealing | RNS |
19.05.2025 15:11 | AREC | Arecor shares climb 18% on collaboration with Skye Bioscience | Alliance |
19.05.2025 07:00 | AREC | Arecor Partnership with Skye Bioscience | RNS |
14.05.2025 14:37 | AREC | Director Dealing | RNS |
08.05.2025 22:00 | SBDS, AREC, BEM | TRADING UPDATES: Big Technologies names new CEO; Van Elle's signs deal | Alliance |
08.05.2025 07:00 | AREC | Arecor sells rights to non-Ogluo® products | RNS |
06.05.2025 16:42 | AREC | Posting of 2024 Annual Report and Notice of AGM | RNS |
24.04.2025 07:00 | AREC | Arecor to present on Investor Meet Company | Reach |
23.04.2025 07:00 | AREC | Grant of Options and PDMR Dealing | RNS |
22.04.2025 11:07 | AREC | Arecor Therapeutics sees "significant future growth" as revenue rises | Alliance |
22.04.2025 07:00 | AREC | Final results for 2024 | RNS |
15.04.2025 14:20 | EBQ, CLIG, AREC | UK earnings, trading statements calendar - next 7 days | Alliance |
10.04.2025 07:00 | AREC | Notice of Results | RNS |
26.03.2025 07:00 | AREC | Collaboration with global pharmaceutical partner | RNS |
12.03.2025 15:34 | AREC | Arecor Therapeutics strikes deal for development of peptide therapy | Alliance |
12.03.2025 07:00 | AREC | Arecor partnership with biopharmaceutical company | RNS |
03.02.2025 13:28 | AREC | Arecor Therapeutics confident for the future as revenue rises | Alliance |
03.02.2025 07:00 | AREC | Arecor Full Year 2024 Trading Update | RNS |
10.01.2025 21:21 | AREC | IN BRIEF: Arecor Therapeutics shares tumble as plans Tetris wind-down | Alliance |
10.01.2025 07:45 | AREC | Orderly Cessation of Tetris Pharma Operations | RNS |
09.01.2025 07:00 | AREC | Change of Nominated Advisor and Joint Broker | RNS |
30.12.2024 11:44 | AREC | IN BRIEF: Arecor Therapeutics signs new drug licensing agreement | Alliance |
30.12.2024 07:00 | AREC | Arecor Signs Exclusive Licensing Agreement | RNS |
02.12.2024 07:00 | AREC | Grant of Options and PDMR Dealing | RNS |
18.11.2024 14:29 | AREC | IN BRIEF: Arecor Therapeutics names David Ellam as interim CFO | Alliance |
27.09.2024 07:00 | AREC | Arecor to present on Investor Meet Company | Reach |
26.09.2024 19:33 | HSD, ENET, FLO | EARNINGS: Hansard Global profit down; Flowtech cuts outlook | Alliance |
26.09.2024 07:00 | AREC | Interim Results for six months ended 30 June 2024 | RNS |
19.09.2024 15:17 | AREC | Notice of Results | RNS |
11.09.2024 07:00 | AREC | Arecor presents positive AT278 data at EASD | RNS |
03.09.2024 07:00 | AREC | Arecor announces AT278 presentation at EASD 2024 | Reach |
22.08.2024 16:34 | AREC | Holding(s) in Company | RNS |
20.08.2024 13:44 | OXH, AREC | Holding(s) in Company | RNS |
12.08.2024 15:02 | AREC | Holding(s) in Company | RNS |
08.08.2024 14:48 | AREC | Result of General Meeting and Total Voting Rights | RNS |